stockportfolio.pro
PTC Therapeutics, Inc. Total Debt 2011–2025
PTC Therapeutics, Inc. (PTCT) annual total debt (short- plus long-term borrowings) by fiscal year, computed from SEC filings.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $0 | -100.0% |
| FY 2024 | $285.41M | +0.4% |
| FY 2023 | $284.21M | -50.3% |
| FY 2022 | $571.72M | +102.8% |
| FY 2021 | $281.89M | -8.8% |
| FY 2020 | $309.14M | +5.2% |
| FY 2019 | $293.86M | +107.9% |
| FY 2018 | $141.35M | -2.5% |
| FY 2017 | $144.97M | +47.6% |
| FY 2016 | $98.22M | +6.9% |
| FY 2015 | $91.85M | — |
| FY 2014 | $0 | — |
| FY 2013 | $0 | -100.0% |
| FY 2012 | $438,810 | — |
| FY 2011 | $0 | — |
Source: PTC Therapeutics, Inc. SEC filings — balance sheet (10-K). Refreshed nightly.
See the full picture for PTC Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePTC Therapeutics, Inc. — frequently asked questions
What is PTC Therapeutics, Inc.'s total debt (short- plus long-term borrowings)?
PTC Therapeutics, Inc. (PTCT) reported total debt (short- plus long-term borrowings) of $0 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from PTC Therapeutics, Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.